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Nickel compounds are potential carcinogenic agents that produce a range of 
biological effects, including inhibition of cell death. Because suppression of 
apoptosis is thought to contribute to the initiation of carcinogenesis, we investigated 
the effects of nickel acetate (Ni
2+
) treatment on apoptosis in two different airway 
epithelial cell lines (A549 and Beas-2B, respectively). Furthermore, since both the 
epidermal growth factor receptor (EGFR) and neuregulin (Neu) are involved in 





, respectively) were also measured. We found 
that exposure of A549 cells to Ni
2+
 resulted in significantly reduced cell viability, as 
well as increased apoptosis and DNA fragmentation at relatively low concentrations 
(0.1 and 0.5mM) after 24 and 48h. These changes were accompanied by reduced 
EGFR and Neu mRNAs and proteins, phosphorilated proteins as well as decreased 
Bcl-2 and increased BAX protein expression. Conversely, Beas-2B cells exposed to 
equivalent concentrations of Ni
2+
 did not show evident signs of apoptosis and DNA 
damage, hence showing increased expression and phosphorilation of both EGFR and 
Neu, increased Bcl-2 and reduced BAX expression. Altogether, our finding indicate 
that Ni
2+
 exposure differently affects apoptosis initiation either in non-tumorigenic 
(Beas-2B) and tumorigenic airway epithelial cells (A549), suggesting a potential 
involvement of EGFR / Neu  receptors.     
 




































































1. Introduction  
 
Occupational exposure to nickel compounds occurs in a variety of industrial 
processes. Aerosols of nickel salts are the types of exposure found in the 
electroplating and electrolysis areas of nickel refineries (Costa, 2002). However, the 
release of nickel into the environment represents a potential for nonoccupational 
exposure (Denkhaus and Salnikow, 2002). Nickel compounds can enter the body 
through inhalation, ingestion, and dermal absorption (Costa, 2002; Sivulka, 2005). 
Epidemiological studies have associated occupational exposure to nickel compounds 
to elevated incidence of cancer in the respiratory tract, such as nasal and lung cancer 
(Kasprzak et al., 2003). Studies performed both in vitro and / or using experimental 
animals in vivo have also confirmed the carcinogenic potential of nickel compounds 
(Kasprzak et al., 2003; Cangul et al., 2002). It has been reported that nickel 
compounds can regulate the expression of specific genes related to tumor 
development (Salnikow and Costa, 2000), however, the molecular mechanisms 
involved have not been clearly identified. 
The epidermal growth factor (EGF) receptors belong to the subclass 1 of the receptor 
tyrosine kinase (RTK) superfamily. There are four EGF receptor family members: 
EGFR (ErbB1 or HER1), Neu (ErbB2 or HER2), ErbB3 (HER3) and ErbB4 (HER4). 
These receptors are situated at the cell membrane and have an extracellular ligand-
binding region, a transmembrane region and a cytoplasmic tyrosine-kinase domain. 




































































activation of the intrinsic kinase domain and phosphorylation of specific tyrosine 
residues within the cytoplasmic tail. Proteins dock on these phosphorylated residues 
lead to the activation of a variety of intracellular signaling pathways that promote cell 
growth, proliferation, differentiation, and migration (Zandi et al., 2007; Olayioye et 
al., 2000; Baselga and Arteaga, 2005; Yarden and Sliwkowski, 2001). Cooperation 
between the various EGF receptors has been observed in oncogenic transformation 
both in vitro and in human primary tumors. In particular, both EGFR and Neu 
receptors seem to play a crucial role in the development of different neoplasms, 
acting either by promoting abnormal cell growth or by inhibiting apoptosis 
(Mosesson and Yarden, 2004). 
Apoptosis is a physiological event that naturally occurs in cells, and once activated, 
may represent a protective mechanism against neoplastic development. In fact, 
aberrant disruption of the apoptotic function allows damaged or transformed cells to 
escape inappropriately from programmed cell death and potentially to proliferate, 
further providing the initiating events that lead to cancer development (Wyllie et al., 
1999; Liu et al., 2001; Correa and Miller, 1998). Several findings have reported that 
nickel compounds may either promote apoptosis or cell resistance in different cell 
types (Ahamed, 2011; Ding et al., 2006; Pan et al., 2011). These opposite effects 
might depend on the different activation of specific target membrane receptors and / 
or molecular pathways. In a previous work we have shown that exposure to 
hexavalent chromium induced changes in the expression of EGF receptors in human 




































































metal-induced lung cancer development (Castorina et al., 2008). To date, however, it 
has not been established whether nickel exposure modifies EGFR / Neu receptors 
activation in airway epithelial cells.  
In the present study we have hypothesized that (1) nickel acetate (Ni
2+
)-treatment 
might differently affect apoptosis initiation in two airway epithelial cell lines and that 
(2) Ni
2+
-induced changes in the activation state of EGFR / Neu receptors might 
contribute to the diverse biological response. For this purpose, comparative analyses 
of cell viability, apoptosis, DNA damage, as well as the expression of the 
antiapoptotic protein Bcl-2 and the proapoptotic protein BAX were performed both in 
tumorigenic alveolar type 2-like (A549) and non-tumorigenic bronchial epithelial 
cells (Beas-2B) exposed to different concentrations of Ni
2+
. Furthermore, to correlate 
these results to changes in EGFR and Neu expression and / or activation state, 
mRNAs, total and phosphorilated protein levels were also measured in both cell lines. 
In conclusion, our finding suggest that Ni
2+
 exposure may differently regulate 
apoptosis initiation in two epithelial cell lines derived from the human respiratory 
tract and support the potential involvement of EGFR and Neu receptor in mediating 
this effect.  
 
2. Materials and methods 
 




































































Human alveolar type 2-like (A549) and bronchial epithelial cells (Beas-2B) were 
purchased from ATCC (cat no. CCL-185 and CRL-9609, respectively). Both cell 
lines were maintained in epidermal growth factor (EGF)-free Dulbecco modified 
Eagle medium (DMEM) containing 500 mg / L glucose, L-glutamine, 100 mg / L 
sodium pyruvate supplemented with 10 % FBS, 0.02 M / L HEPES, 100 U / mL 
penicillin, and 50 ng / mL streptomycin. Cells were grown in an incubator at 37 °C in 
a humidified atmosphere with 5 % CO2 and passaged at 80 % confluence. 
 
2.2 Cell viability (MTT assay)  
To assess cell viability, we used the cell proliferation kit I (MTT) following 
manufacturer's instructions (Roche). Cells were seeded into 96-well plates at a 
concentration of 1 × 10
4
 cells / well and allowed to adhere for 24h. Cells were then 
treated either with a range of concentrations (0, 0.1, 0.5, 1, 2.5 and 5 mM, 
respectively) of nickel acetate (Ni
2+
) (Sigma Aldrich) for 24h for dose-response 
analyses or with 0.1 mM Ni
2+
 for 24, 48, 72h and 1 week for time-course analyses. 
EGF-free DMEM containing 0.5 mg / mL 3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide (MTT) (Sigma–Aldrich) was added in each well. 
Following incubation for 4h at 37 °C, medium was removed, and 100 μL of DMSO 
was added. Formazan formed by the cleavage of the yellow tetrazolium salt MTT 






































































2.3 Apoptotic assay by immunodetection of oligonucleosomes 
Mononucleosomes and oligonucleosomes released from the nucleus into the 
cytoplasm of apoptotic cells were detected with the use of a sandwich enzyme-linked 
immunosorbent assay (The Cell Death Detection) ELISA
PLUS
 10× (Roche Applied 
Sciences). The assay is based on quantitative sandwich enzyme-linked 
immunosorbent assay principle, with mouse monoclonal antibody direct against DNA 
histones, respectively. For sample preparation, both A549 and Beas-2B cells treated 
with 0.1 mM Ni
2+
 for 24, 48, 72h and 1 week were harvested by trypsinization. Cells 
were lysed in incubation buffer for 30 min. The lysate was then centrifuged at 
20.000g × 10 min. Supernatant was diluted to yield 1 × 10
4
 cell equivalents / mL and 
used for immunodetection. The assay was performed as follows: (1) an antibody that 
react with the histone H1, H2A, H2B, H3 and H4 was fixed on the wall of the 
microplate module provided with the kit; (2) samples prepared as described above 
were added to the plate containing the immobilized anti-histone antibody; (3) anti-
DNA monoclonal antibodies conjugated to peroxidase were added, to allow their 
binding to the DNA part of nucleosomes; and (4) after removal of unbound 
peroxidase conjugate, the amount of peroxidase retained in the immunocomplex was 
determined photometrically with 2,2′-azino-di(3-ethylbenzthiazoline sulfonate) as a 
substrate. 
 




































































A549 and Beas-2B cells were exposed to 0.1 mM Ni
2+ 
for 24 and 48h. The typical 
morphological features of apoptotic degeneration were analyzed by the use of 
fluorescence microscopy with the nuclear dye Hoechst 33258 (Forloni et al., 1993). 
Cells were fixed with a solution of methanol / acetic acid (3 : 1 v / v) for 30 min, 
washed three times in PBS and incubated for 15 min at 37 °C with 0.4 μg / mL 
Hoechst 33258 dye. After being rinsed in water, cells were visualized for 
determination of nuclear chromatin morphology with the use of an Axiovert 40 
fluorescence microscope (Carl Zeiss Inc.). Apoptotic cells were recognized on the 
basis of nuclear condensation and / or fragmented chromatin. Each condition was 
reproduced in three dishes per experiment. Both apoptotic and normal cells were 
determined by analyzing at least three different fields per dish in a fixed pattern. 
 
2.5 Analysis of mRNA expression by RT-PCR 
Total RNA extracts obtained from untreated A549 and Beas-2B cells were isolated 
by 1 mL TRIzol reagent (Invitrogen) and 0.2 mL chloroform and precipitated with 
0.5 mL isopropanol. Pellet was washed with 75 % ethanol and air dried. Single 
stranded cDNAs were synthesized incubating total RNA (5 μg) with SuperScript III 
RNase H-reverse transcriptase (200 U / μL) (Invitrogen); Oligo-(dT)20 primer 
(100 nM) (Invitrogen); 1 mM dNTP mix (Invitrogen), dithiothreitol (DTT, 0.1 M), 
Recombinant RNase-inhibitor (40 U / μL) at 42 °C for 1h in a final volume of 20 μL. 
Reaction was terminated by incubation of samples at 70 °C for 10 min. Aliquots of 




































































S18 ribosomial subunit. Oligonucleotide sequences are listed in Table 1. Each PCR 
reaction contained 0.4 μM specific primers, 200 μM dNTPs, 1.25 U AmpliTaq Gold 
DNA polymerase and GeneAmp buffer containing 2.5 mM MgCl
2+
 (Applied 
Biosystem). PCR was performed using the following three cycle programs: (I) 
denaturation of cDNA (1 cycle: 95 °C for 12 min); (II) amplification (40 cycles: 
95 °C for 30 s, 60 °C for 30 s, 72 °C for 45 s); (III) final extension (1 cycle: 72 °C for 
7 min). Amplification products were separated by electrophoresis in a 1.8 % agarose 
gel in 0.045 M Tris–borate / 1 mM EDTA (TBE) buffer. 
 
2.6 Real-time quantitative PCR analysis   
Aliquots of cDNA (400 ng) from either untreated or 0.1 mM Ni
2+
-treated A549 and 
Beas-2B cells at different times (24 and 48 h, respectively) were amplified in parallel 





 copies) using specific primer pairs listed in Table 1. To normalize 
data, mRNA levels of the S18 ribosomial subunit (reference gene) were measured in 
each amplification. Each PCR reaction (final volume of 20 μL) contained 0.5 μM 
primers, 1.6 mM Mg
2+
, 1× Light Cycler-FastStart DNA Master SYBR Green I 
(Roche Diagnostic). Amplifications were performed using a Light Cycler 1.5 
instrument (Roche Diagnostic) with the following program setting: (I) cDNA 
denaturation (1 cycle: 95 °C for 10 min); (II) quantification (45 cycles: 95 °C for 
10 s, 57 °C for 7 s, 72 °C for 5 s); (III) melting curve analysis (1 cycle: 95 °C for 0 s, 




































































amplification was carried out in duplicate in at least three different experiments. The 
temperature transition rate was 20 °C / s, except for the third segment of the melting 
curve analysis where it was set to 0.1 °C / s. Quantification was obtained by 
comparing the fluorescence emitted by PCR products at unknown concentration with 
the fluorescence emitted by external standards at known concentration. For this 
analysis, fluorescence values, measured in the log-linear phase of amplification, were 
estimated with the second derivative maximum method using Light Cycler Data 
Analysis software. PCR products specificity was evaluated by melting curve analysis 
followed by gel electrophoresis. 
To assess the different expression levels we employed the well-established ΔCt 
comparative method (Schmittgen and K.J. Livak, 2008). We analyzed the mean of 
the crossing points (or crossing threshold = Ct) of each sample. The Ct represents the 
number of cycles needed to detect a fluorescence above a specific threshold level and 
it is inversely correlated to the amount of nucleic acids template present in the 
reaction. The ΔCt was calculated by normalizing the mean Ct of each sample to the 
mean Ct of the reference gene measured in the same experimental conditions. For 
quantification of each gene we considered either untreated A549 or Beas-2B cultures 
as positive samples (calibrator sample). The ΔΔCt of each sample was calculated by 
subtracting calibrator ΔCt to sample ΔCt. The formula 2
−ΔΔCt
 was used to calculate 
the fold change. 
 




































































Crude extracts were prepared by homogenizing cells in a buffer containing 20 mM 
Tris (pH 7.4), 2 mM EDTA, 0.5 mM EGTA; 50 mM mercaptoethanol, 0.32 mM 
sucrose and a protease inhibitor cocktail (Roche Diagnostics) supplemented with 
phosphatase inhibitors (Roche Diagnostics) using a Teflon-glass homogenizer and 
then sonicated. Protein concentrations were determined by Bradford's method 
(Bradford, 1976) using BSA as a standard. Sample proteins (50 μg) were diluted in 
4× sodium dodecyl sulfate (SDS) protein gel loading solution (Invitrogen), boiled for 
10 min, separated on 4–12 % Bis–Tris gel (Invitrogen) by electrophoresis and 
processed as previously described by Pascale et al., 1996. 
Immunoblot analysis was performed by using polyclonal antibodies listed below: 
rabbit polyclonal IgG raised against a peptide mapping at the C-terminus of EGFR of 
human origin (sc-03, Santa Cruz Biotechnology, Inc.), rabbit polyclonal IgG raised 
against epitope corresponding to phosphorylated Tyr 1173 of  EGFR of human origin 
(sc-03, Santa Cruz Biotechnology, Inc.), mouse monoclonal raised against the 
extracellular domain of Neu of human origin (sc-74241, Santa Cruz Biotechnology, 
Inc.), rabbit polyclonal IgG raised against epitope corresponding to a short amino 
acid sequence containing phosphorylated Tyr 1248 of Neu of human origin (sc-
12352, Santa Cruz Biotechnology, Inc.), mouse monoclonal IgG1 raised against a 
synthetic peptide corresponding to amino acids 41-54 of human Bcl-2 (sc-509, Santa 
Cruz Biotechnology, Inc.), rabbit polyclonal IgG, raised against a epitope mapping at 
the N-terminus of BAX of human origin (sc-493, Santa Cruz Biotechnology, Inc.) 




































































444 mapping at the C-terminus of β-tubulin of human origin (sc-9104, Santa Cruz 
Biotechnology, Inc.) which was used as loading control. All primary antibodies were 
diluted 1 : 200, while secondary antibodies (HRP-conjugated goat anti-mouse and 
anti-rabbit antibodies, Amersham Biosciences) were used at 1 : 10000. Blots were 
developed using enhanced chemiluminescence technique (Amersham Biosciences). 
No signal was detected when the primary antibody was omitted (data not shown). 
 
2.8 Statistical analysis 
Statistical analysis was performed using GraphPad InStat version 3.00, GraphPad 
Software Inc., San Diego CA, USA). Paired comparisons were performed using the 
two-tailed Student t-test. One-way analysis of variance (ANOVA) was used to 
compare differences among three or more data sets and statistical significance was 
assessed by Tukey-Kramer post-hoc test, unless otherwise indicated. The level of 




3.1Dose-response effect of Ni
2+
 treatment on cell viability in A549 and Beas-2B cells  
To investigate the effect of Ni
2+
 treatment on cell viability, both A549 and Beas-2B 
cells were exposed to increasing concentrations of Ni
2+
 (0, 0.1, 0.5, 1, 2.5 and 5 mM, 
respectively) for 24h and MTT analyses were performed. As indicated in Fig. 1, 
exposure to Ni
2+ 




































































in Beas-2B cells. In particular, with respect to untreated controls, percentage of cell 
viability in A549 cells was significantly reduced already at 0.1 mM Ni
2+ 
(*p<0.05 Vs 
Control, ANOVA followed by Tukey-Kramer post-hoc test) and further declined 
with higher Ni
2+ 
concentrations (0.5, 1, 2.5 and 5 mM, respectively, ***p<0.001 Vs 
Control). Conversely, Beas-2B cells showed reduced susceptibility to Ni
2+
 treatment, 
with cell viability being significantly reduced only at concentrations >= 1 mM 
(**p<0.01 or ***p<0.001 Vs Control). Furthermore, comparative analyses revealed 
that Ni
2+
-induced differences in cell viability between the two cell lines reached 
statistical significance at 0.1 mM Ni
2+
 (#p<0.05 Vs Ni
2+
-treated A549 cells) and 
further increased at higher concentrations (##p<0.01 or ###p<0.001 Vs Ni
2+
-treated 
A549 cells) (Fig. 1).  
 
3.2 Time-course of Ni
2+
-induced effects on cell viability in A549 and Beas-2B cells 
To evaluate the effects of Ni
2+
 exposure on cell viability over time, MTT analyses 
were carried out either in untreated A549 or Beas-2B cells (Control) or cells exposed 
to 0.1 mM Ni
2+
 for 24, 48, 72h and 1 week.  Our finding demonstrated that a 
relatively low concentration of Ni
2+
 (0.1 mM) was sufficient to cause significant 
reduction of cell viability in A549 cells at every time point considered, reaching the 
maximum effect after 72h (***p<0.001 Vs Control, unpaired Student t-test) (Fig. 
2A). Oppositely, Beas-2B cells survival rate was not affected by 0.1 mM Ni
2+
 
exposure neither after 24 and 48h, whereas a significant reduction was observed after 




































































results suggested that Beas-2B cells might be more resistant to Ni
2+
–induced cell 
death than A549.  
 
3.3 Oligonucleosomes formation and DNA damage in Ni
2+
-treated A549 and Beas-2B 
cells  
To establish whether the previously observed effects of Ni
2+
 treatment on cell 
viability in A549 and Beas-2B cells could be associated to the activation of an 
apoptotic process we performed an enzyme-linked immunosorbent assay for the 
detection of mono- / oligonucleosomes. A549 and Beas-2B cells were treated with 
0.1 mM Ni
2+
 for the indicated times and apoptotic levels were measured. We found 
that in Ni
2+
-treated A549 cells apoptosis was significantly increased as compared to 
control (untreated cells at time 0) both after 24 and 48h (*p<0.05 Vs Control; 
ANOVA followed by Tukey-Kramer post-hoc test). Prolonged exposure to Ni
2+
 (72h 
and 1 week, respectively) further increased apoptotic levels in A549 cells (**p<0.01 
Vs Control) (Fig. 3A). In contrast to A549 cells, Ni
2+
 treatment was not able to trigger 
apoptosis in Beas-2B cells after 24 and 48h, but required longer periods of exposure 
(72h and 1 week, respectively) to produce a significant increase in apoptotic levels 
(*p<0.05 and **p<0.01 Vs Control) (Fig. 3A). Evidence of a disparity in apoptotic 
response to Ni
2+
 treatment between the two cell lines was also confirmed statistically, 
showing significant changes in oligonucleosome formation between Ni
2+
-treated 
Beas-2B and A549 cells (#p<0.05 Vs Ni
2+
-treated A549 cells at the indicated times) 






































































-treated A549 and Beas-2B cells were stained with the Hoechst 33342 
nuclear dye (Fig. 3B). After 24 and 48h treatment, A549 cells exposed to Ni
2+
 
showed evident signs of DNA damage with respect to untreated controls, whereas 
apparent normal morphology persisted in Ni
2+
-treated Beas-2B cells (Fig. 3B).   
 
3.4 Identification of EGFR and Neu receptor mRNAs in A549 and Beas-2B cells  
 RT–PCR analysis was performed both in A549 and Beas-2B cells to evaluate 
whether these cell lines express EGFR and Neu receptor mRNAs. Amplification 
products obtained using specific primer pairs (Table 1) demonstrated that EGFR and 
Neu receptor genes are expressed in both cell lines (Fig. 4). Primers for the 
constitutively expressed S18 ribosomal subunit were used as control in each PCR 
amplification and generated bands of the expected length.  
 
3.5 EGFR and Neu receptor mRNA expression in Ni
2+
-treated A549 and Beas-2B  
To investigate whether Ni
2+
 treatment affected either EGFR and / or Neu receptor 
expression, both A549 and Beas-2B were treated with 0.1 mM Ni
2+
 for 24 and 48h 
and subsequently transcript levels were measured by quantitative real-time PCR 
analyses. Our finding indicate that EGFR and Neu receptor genes were differentially 
affected by Ni
2+
 exposure in either cell line after 24 and 48h (Table 2). Data obtained 
from these analyses showed that, as compared to untreated controls, EGFR and Neu 
expression levels were significantly decreased with treatment in A549 cells (*p<0.05 






































































-treated Beas-2B cells showed a significant increase in both genes 
mRNAs after 24h (**p<0.01 Vs Control), whereas such significant increase in gene 
expression was evident for Neu receptor (**p<0.01 Vs Control) but not for EGFR 
after 48h.  
 




Western blot analyses were performed to examine the effects of Ni
2+
 treatment on 
EGFR and Neu receptor protein levels as well as in their phosphorylated forms both 
in A549 and Beas-2B cells after 24 and 48h. Cells were maintained either in EGF-
free medium (Ctrl), treated with 100 ng / mL EGF (Sigma) (positive control, +EGF) 




-treated) at the indicated times. As displayed in Fig. 
5, total EGFR and Neu receptor protein expression showed high correspondence with 
mRNA measurements, although a correlation between transcript and protein levels 
may not always be found (Sonenberg and Hinnebusch, 2009). Interestingly, the 
expression of phosphorylated proteins (p-EGFR and p-Neu, respectively) was 
oppositely regulated by Ni
2+ 
exposure in the two cell lines (Fig. 5A). More 
specifically, in A549 cells, both p-EGFR and p-Neu expression was downregulated in 
response to Ni
2+
 treatment after 24 and 48h, whereas in Beas-2B cells, treatment 
upregulated both p-EGFR and p-Neu expression (Fig. 5A), suggesting that Ni
2+
 might 
differentially regulate EGFR and Neu activation state in the two cell lines. To find a 




































































triggering of apoptosis after metal treatment, the expression of the antiapoptotic 
protein Bcl-2 and the proapoptotic protein BAX were also analyzed in both cell lines. 
As demonstrated in Fig. 5B, Ni
2+
-treated A549 cells showed decreased Bcl-2 and 
increased BAX expression both after 24 and 48h, whereas in Beas-2B cells, Ni
2+
 
caused the induction of the antiapoptotic Bcl-2 and markedly reduced BAX 
expression, implying a possible inverse correlation between EGFR / Neu 
phosphorilation levels and the activation of the intrinsic apoptotic pathway.   
 
4. Discussion  
 
The correlation between nickel compounds exposure and increased risk of human 
respiratory cancer has been widely reported in epidemiologic studies (Kasprzak et al., 
2003). However, the exact mechanisms of nickel-induced carcinogenesis are not yet 
clearly  understood. Since inhalation is one of the main occupational exposure routes 
of nickel exposure (Costa, 2002; Sivulka, 2005), human alveolar type 2-like (A549) 
and human bronchial epithelial cells (Beas-2B) were used in this study. These are 
well-established cell lines and have been extensively used to investigate the effects of 
environmental pollutants (Wilson et al., 2000; Laan et al., 2004; Kawasaki et al., 
2001). 
In the present study we have shown that Ni
2+ 
exposure differentially affected both cell 
viability and apoptosis in two distinct airway epithelial cell lines. More specifically, 






































































significantly reduced cell viability (Fig. 1 and 2) and increased apoptosis and DNA 
damage in A549 cells (Fig. 3). Oppositely, equivalent concentrations of the metal 
were not able to produce any significant biological effect in cell viability and 
apoptosis in Beas-2B cells (Fig. 1-3), indicating, at least in part, a decreased 
susceptibility of bronchial compared to alveolar epithelial cells to Ni
2+
-induced cell 
death. These results are consistent with previous finding showing the effect of nickel 
in different cell lines, which demonstrated that the metal either promoted apoptosis 
resistance in Beas-2B cells (Ding et al., 2006; Pan et al., 2011) or induced apoptosis 
in other cell lines, like T cell hybridoma cells, Jurkat cells, and mouse epidermal JB6 
cells (Shiao et al., 1998; Kim et al., 2002; Zhao et al., 2009). However, the molecular 
mechanisms by which nickel might trigger apoptosis in some cell types and not in 
others remain to be fully understood. According to literature data, reactive oxygen 
species (ROS) generation (Salnikow et al., 1994; Pan et al., 2010), transcription 
factor activation (Cruz et al., 2004; Salnikow et al., 2003) as well as 
hypermethylation (Lee et al., 1995) are the main events that occur in nickel-induced 
carcinogenesis. Nonetheless, it has also been postulated that nickel compounds might 
also have a role in the regulation of sets of genes important in normal growth control 
(Mollerup et al., 1996). Based on these finding, we sought to investigate whether the 
different sensitivity of cells to nickel treatment could be associated to a differential 
regulation in the expression and activation state of two members of the EGF receptor 
family, termed EGFR and Neu. These receptors have been shown to be differently 




































































activating molecular pathways that either promoted proliferation or induced cell 
death (Wu et al., 1999; Castorina et al., 2008; Kundu et al., 2011). Here we showed 
that exposure of A549 cells to subtoxic doses of Ni
2+
 reduced both total EGFR and 
Neu mRNA and protein expression, as well as their respective phosphorilated 
proteins, whereas induction of gene and protein expression and a concurrent increase 
in the activation state of EGFR and Neu were observed in Ni
2+
-exposed Beas-2B 
cells (Table 2 and Fig. 5A), although increased phosphorilation could not be 
associated with promotion of cell proliferation. The latter finding is supported by 
previous reports indicating that agents other than EGF family member ligands may 
induce EGF / Neu receptor tyrosine phosphorylation (Li et al., 1998; Zwick et al., 
1997) and that nickel may induce apoptosis resistance in Beas-2B cells without 
affecting cell growth (Ding et al., 2006). Our data showing that Ni
2+
 exposure can 
activate these two EGF receptors in Beas-2B cells are similar to previous findings by 
Chen et al., 1998 who observed the role of EGFR in mediating arsenite-induced 
protein tyrosine phosphorylation in pheochromocytoma cells. Although the 
mechanism responsible for metal-induced activation of EGF receptor tyrosine kinase 
is unknown, it is possible that nickel may directly interact with the EGF receptor 
molecules, causing a structural alteration or dimerization that results in activation of 
the kinase domain. A further explanation for the decreased / increased expression of 
p-EGFR and p-Neu in A549 and Beas-2B cells could be that nickel acts by either 
activating or inactivating phosphatases that serve to dephosphorylate EGFR and Neu, 




































































nickel-induced ROS generation may vary among different cell types, ultimately 
leading to membrane changes that can either promote or reduce receptor activation, 
hence causing either inactivation or activation of apoptosis. Although further studies 
are required to confirm these possibilities, both nickel-induced phosphatase- and 
ROS-dependent potential effects on receptors activation represent a plausible 
explanation for the differential effects of nickel in A549 and Beas-2B cells. However, 
since we found that subtoxic nickel exposure decreased the expression of the 
antiapoptotic Bcl-2 protein and increased BAX protein levels in A549 cells, whereas 
it increased Bcl-2 and decreased BAX expression in Beas-2B cells (Fig. 5B), we also 
suggest that changes in levels of phosphorilated EGFR and Neu may potentially 
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Figure 1. Dose-response effect of Ni
2+
 treatment on cell viability in A549 and 
Beas-2B cells 
Cell viability was assessed in A549 and Beas-2B cells exposed to increasing 
concentrations of Ni
2+
. Cells were treated with a range of concentrations (0, 0.1, 0.5, 
1, 2.5 and 5 mM) of Ni
2+
 for 24 h and processed for MTT measurements as described 
in ‘Materials and methods’. Values are expressed as percentage of cell viability in 
untreated controls (n = 3) ± SD.  Results are representative of three independent 
experiments. *p<0.05, **p<0.01 or ***p<0.001 Vs untreated cells; #p<0.05, 
##p<0.01 or ###p<0.001 Vs Ni
2+
-treated A549 cells (One-Way ANOVA followed 
by Tukey post-hoc test).. 
 
Figure 2. Time-course of Ni
2+
-induced effects on cell viability in A549 and Beas-
2B cells 
Cell viability was measured in A549 (A) and Beas-2B cells (B) exposed to 0.1 mM 
Ni
2+
 at different time points (24, 48, 72h and 1 week, respectively). Untreated 
(Control) or Ni
2+
-treated cells at the indicated times were processed for MTT 
measurements as detailed in ‘Materials and Methods’. Values are expressed as mean 
ODs (n = 3) ± SD. Results are representative of three independent experiments. 
*p<0.05, **p<0.01 or ***p<0.001 Vs Control at the indicated time (two-tailed 





































































Figure 3. Oligonucleosomes formation and DNA damage in Ni
2+
-treated A549 
and Beas-2B cells 
Effect of Ni
2+
 exposure on apoptosis in A549 and Beas-2B cells as determined by 
oligonucleosomes detection (A) and Hoechst 33258 nuclear staining (B). (A) Cells 
were treated with 0.1 mM Ni
2+
 for indicated times and processed for 
oligonucleosomes detection as described in ‘Material and Methods’. Values are 
expressed as mean ODs (n = 3) ± SD. Oligonucleosomes formation in untreated cells 
is indicated as time point 0. *p<0.05 or **p<0.01 Vs untreated cells; #p<0.05 Vs 
Ni
2+
-treated A549 cells (One-Way ANOVA followed by Tukey post-hoc test). (B) 





on DNA damage in A549 and Beas-2B cells after 24 and 48h. Untreated cells are 
indicated as Control. Cells were stained with the fluorescent nuclear dye Hoechst 
33258 and viewed at 40× magnification. Results shown are representative of three 
independent experiments. Scale bar = 50μm. 
 
Figure 4. Identification of EGFR and Neu receptor mRNAs in A549 and Beas-
2B cells  
Amplification products obtained using specific primer pairs (Table 1) demonstrated 
that both EGFR and Neu receptor genes are expressed in both A549 and Beas-2B 
cells (Fig. 4). Primers for the constitutevely expressed S18 ribosomal subunit were 




































































length. A 100-bp DNA ladder is shown on the left side of each gel (lane M) with 
bands labelled in bp units. 
 
Figure 5. EGFR and Neu activation, Bcl-2 and BAX expression in A549 and 
Beas-2B exposed to Ni
2+
 
Western blot analyses showing Ni
2+
-induced changes in the expression of total and 
phosphorilated EGFR and Neu receptor protein (A) as well as Bcl-2 and BAX 
expression (B) in A549 and Beas-2B after 24 and 48h. Representative immunoblots 
were obtained using 50 μg of cell homogenates from either untreated (Ctrl), 100 ng / 
mL EGF-treated (positive control, +EGF) or Ni
2+
-treated A549 and Beas-2B cells at 
the indicated times. β-Tubulin was used as loading control in each experiment. The 










Table 1. Primer sequences 
Gene Forward primer Reverse primer bp 
EGFR 
Acc # NM005228.3 
GTTGAGGGCAATGAGGACAT AACTGTGAGGTGGTCCTTGG 114 
Neu 
Acc # NM00448.2 
CCCACGTCCGTAGAAAGGTA ACAGTGGCATCTGTCAGCTG 148 
S18 
Acc # NM022551.2 
GGACCTGGCTGTATTTTCCA GAGGATGAGGTGGAACGTGT 115 
 
Forward and reverse primers were selected from the 5′ and 3′ region of each gene 
mRNA. The expected length of PCR products is indicated in the right column 
Table 1
  
Table 2. Identification of EGFR and Neu receptor mRNAs in A549 and Beas-2B 
cells 
Cell line Gene 
Treatment 
Control (untreated) Ni2+-treated after 24h Ni2+-treated after 48h 
mean fold change ± SEM 
A549 
EGFR 1.00 ± 0.11 0.7 ± 0.12* 0.54 ± 0.04** 
Neu 1.04 ± 0.14 0.34 ± 0.06** 0.73 ± 0.08* 
Beas-2B 
EGFR 1.02 ± 0.12 1.59 ± 0.04** 1.14 ± 0.06 
Neu 1.03 ± 0.10 1.40 ± 0.06** 1.51 ± 0.09** 
 
A549 and Beas-2B cells were either left untreated (Control) or treated with 0.1 mM 
Ni
2+
 for 24 and 48h. EGFR and Neu receptors mRNAs were measured by quantitative 
real-time PCR analysis as described in ‘Materials and Methods’. Results are 
presented as mean fold change of control groups (Control, n=3) ± SEM. Relative fold 
changes of target genes obtained after normalization to the endogenous ribosomal 
protein S18 (housekeeping gene) were calculated according to the comparative ΔCt 
method (Schmittgen and Livak, 2008). Baseline expression levels of the control 
groups were set to 1. Results are representative of three independent experiments, 
each run in duplicate. *p<0.05 or **p<0.01 Vs Control (One-Way ANOVA followed 
















Beas-2B are less susceptible than A549 cells to Ni
2+




 exposure differently regulates EGFR/Neu activation in the two cell lines 
 
EGFR/Neu expression and activation is increased in Ni
2+
-exposed Beas-2B but not in A549 cells  
 
EGFR/Neu activation is correlated with increased Bcl-2 and reduced BAX levels   
 
 
  
 
 
 
  
*Highlights
